• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    Vimseltinib
    |
    Weekly News Recap #Phispers Vimseltinib
    US health agencies brace for more layoffs under RFK Jr; Novo alleges fraud in US$ 1.3 bn deal with KBP BioSciences

    US health agencies brace for more layoffs under RFK Jr; Novo alleges fraud in US$ 1.3 bn deal with KBP BioSciences

    In this week’s Phispers, we bring you news from the public health agencies in the US that have already witnessed consider...

    Impressions : 1104

    FTC disputes relevance of over 300 patent listings; Japan’s Ono to buy Deciphera for US$ 2.4 bn

    FTC disputes relevance of over 300 patent listings; Japan’s Ono to buy Deciphera for US$ 2.4 bn

    The price of drugs is the highest in the US, and the White House has been working on bringing down drug prices for several year...

    Impressions : 1328

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.